切换导航
News
All Journals
All Articles
Subscribe
Sign up for updates about the journal.
Subscribe
Sign in
Register
Exploration of Targeted Anti-tumor Therapy
切换导航
3.1
CiteScore
PubMed
Indexed
Submit Manuscript
About
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
About
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
Search
All Journals
Exploration of Medicine
Exploration of Targeted Anti-tumor Therapy
Exploration of Immunology
Exploration of Neuroprotective Therapy
Exploration of Digestive Diseases
Exploration of Neuroscience
Exploration of Musculoskeletal Diseases
Exploration of Drug Science
Exploration of Asthma & Allergy
Exploration of Foods and Foodomics
Exploration of Digital Health Technologies
Exploration of Cardiology
Exploration of BioMat-X
Exploration of Endocrine and Metabolic Diseases
All
Article Title
Abstract
Author
Keywords
Institution
Home
/
Exploration of Targeted Anti-tumor Therapy
/
Articles
/
T1
From:
Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response
Table 1.
Lipid components for the various liposome formulations
Formulation
DOPE (mol%)
DMAPAP (mol%)
YUK1390 (mol%)
YUK1350 (mol%)
DOPE:DMAPAP
50
50
0
0
DOPE:DMAPAP:YUK1350
50
25
0
25
Return to article view